RGLS insider transaction filings
Regulus Therapeutics Inc. — 27 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-06-27. Screen RGLS transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-06-27 | 4 | Witz Pascale — Director | Disposition to issuer (D): 67,233 · Disposition to issuer (D): 4,650 (derivative) · Disposition to issuer (D): 2,325 (derivative) · Disposition to issuer (D): 4,000 (derivative) · Disposition to issuer (D): 9,000 (derivative) · Disposition to issuer (D): 30,000 (derivative) · +4 more | EDGAR |
| 2025-06-27 | 4 | Rosen Hugh — Director | Code (U): 6,979 · Disposition to issuer (D): 57,292 · Disposition to issuer (D): 4,650 (derivative) · Disposition to issuer (D): 2,325 (derivative) · Disposition to issuer (D): 4,000 (derivative) · Disposition to issuer (D): 9,000 (derivative) · +4 more | EDGAR |
| 2025-06-27 | 4 | Aker Christopher Ray — Sr. VP & General Counsel | Code (U): 60,796 · Disposition to issuer (D): 83,125 · Disposition to issuer (D): 2,500 (derivative) · Disposition to issuer (D): 750 (derivative) · Disposition to issuer (D): 33,500 (derivative) · Disposition to issuer (D): 21,000 (derivative) · +7 more | EDGAR |
| 2025-06-27 | 4 | Huang Alice Shih-hou — Director | Code (U): 5,208 · Disposition to issuer (D): 57,292 · Code (U): 27,377 · Disposition to issuer (D): 57,292 · Disposition to issuer (D): 4,000 (derivative) · Disposition to issuer (D): 9,000 (derivative) · +12 more | EDGAR |
| 2025-06-27 | 4 | Collier Kathryn J — Director | Disposition to issuer (D): 75,565 · Disposition to issuer (D): 4,650 (derivative) · Disposition to issuer (D): 9,000 (derivative) · Disposition to issuer (D): 30,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 30,000 (derivative) · +1 more | EDGAR |
| 2025-06-27 | 4 | CALSADA CRISPINA — Chief Financial Officer | Disposition to issuer (D): 140,228 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 21,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 48,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · +5 more | EDGAR |
| 2025-06-27 | 4 | Klassen Preston — President & Head of R & D, Director | Disposition to issuer (D): 115,555 · Disposition to issuer (D): 350,000 (derivative) · Disposition to issuer (D): 225,000 (derivative) · Disposition to issuer (D): 120,000 (derivative) · Disposition to issuer (D): 528,000 (derivative) · Disposition to issuer (D): 675,000 (derivative) | EDGAR |
| 2025-06-27 | 4 | Hagan Joseph P — Chief Executive Officer, Director | Disposition to issuer (D): 571,558 · Disposition to issuer (D): 6,500 (derivative) · Disposition to issuer (D): 1,000 (derivative) · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 90,000 (derivative) · Disposition to issuer (D): 160,000 (derivative) · +7 more | EDGAR |
| 2025-06-27 | 4 | Nunn Jason Raleigh — Director | Disposition to issuer (D): 62,500 · Disposition to issuer (D): 4,650 (derivative) · Disposition to issuer (D): 2,325 (derivative) · Disposition to issuer (D): 4,000 (derivative) · Disposition to issuer (D): 9,000 (derivative) · Disposition to issuer (D): 30,000 (derivative) · +3 more | EDGAR |
| 2025-06-27 | 4 | RASTETTER WILLIAM H — Director | Code (U): 44,264 · Disposition to issuer (D): 57,292 · Disposition to issuer (D): 4,650 (derivative) · Disposition to issuer (D): 2,325 (derivative) · Disposition to issuer (D): 4,000 (derivative) · Disposition to issuer (D): 9,000 (derivative) · +4 more | EDGAR |
| 2025-06-27 | 4 | PAPADOPOULOS STELIOS — Director | Code (U): 976,253 · Disposition to issuer (D): 64,635 · Disposition to issuer (D): 4,650 (derivative) · Disposition to issuer (D): 2,325 (derivative) · Disposition to issuer (D): 4,000 (derivative) · Disposition to issuer (D): 9,000 (derivative) · +5 more | EDGAR |
| 2025-06-27 | 4 | BALTIMORE DAVID — Director | Code (U): 27,377 · Disposition to issuer (D): 57,292 · Code (U): 5,208 · Disposition to issuer (D): 57,292 · Disposition to issuer (D): 4,650 (derivative) · Disposition to issuer (D): 2,325 (derivative) · +12 more | EDGAR |
| 2025-06-18 | 4 | Collier Kathryn J — Director | Option exercise (M): 1,396 @ $9.90 · Option exercise (M): 2,604 @ $9.90 · Option exercise (M): 2,325 @ $8.80 · Option exercise (M): 1,396 (derivative) @ $0 · Option exercise (M): 2,604 (derivative) @ $0 · Option exercise (M): 2,325 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Klassen Preston — President & Head of R & D, Director | Purchase (P): 12,000 @ $7.99 | EDGAR |
| 2025-04-30 | 4 | Huang Alice Shih-hou — Director | Grant/award (A): 62,500 @ $0 · Grant/award (A): 62,500 @ $0 | EDGAR |
| 2025-04-30 | 4 | Witz Pascale — Director | Grant/award (A): 62,500 @ $0 | EDGAR |
| 2025-04-30 | 4 | Collier Kathryn J — Director | Grant/award (A): 62,500 @ $0 | EDGAR |
| 2025-04-30 | 4 | Rosen Hugh — Director | Grant/award (A): 62,500 @ $0 | EDGAR |
| 2025-04-30 | 4 | Nunn Jason Raleigh — Director | Grant/award (A): 62,500 @ $0 | EDGAR |
| 2025-04-30 | 4 | RASTETTER WILLIAM H — Director | Grant/award (A): 62,500 @ $0 | EDGAR |
| 2025-04-30 | 4 | PAPADOPOULOS STELIOS — Director | Grant/award (A): 62,500 @ $0 | EDGAR |
| 2025-04-30 | 4 | BALTIMORE DAVID — Director | Grant/award (A): 62,500 @ $0 · Grant/award (A): 62,500 @ $0 | EDGAR |
| 2025-01-31 | 4 | Aker Christopher Ray — Sr. VP & General Counsel | Grant/award (A): 487,500 (derivative) @ $0 | EDGAR |
| 2025-01-31 | 4 | CALSADA CRISPINA — Chief Financial Officer | Grant/award (A): 562,500 (derivative) @ $0 | EDGAR |
| 2025-01-31 | 4 | Klassen Preston — President & Head of R & D, Director | Grant/award (A): 675,000 (derivative) @ $0 | EDGAR |
| 2025-01-31 | 4 | Hagan Joseph P — Chief Executive Officer, Director | Purchase (P): 50,000 @ $1.09 · Grant/award (A): 1,350,000 (derivative) @ $0 | EDGAR |
| 2025-01-31 | 4 | BALTIMORE DAVID — Director | Purchase (P): 19,610 @ $1.06 | EDGAR |
Recent 8-K events — Regulus Therapeutics Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2025-06-25 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-05-08 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-04-30 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-27 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-04 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=RGLS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →